Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
National Pharmaceutical Council to CVS: Join Us in a Broader Dialogue to Address Health Care Spending
The viewpoints published on the Health Affairs Blog bring an important question to mind: will CVS join the National Pharmaceutical Council and key stakeholders from across the health sector in our ongoing and constructive dialogue about health care spending and value?
In an interview with NPC, Lindsay Videnieks, director of the Headache and Migraine Policy Forum (HMPF), discusses the kind of effort it takes to become involved in the ICER value assessment process, what her organization learned along the way and how ICER’s patient engagement process could be improved.
In his latest commentary for Chain Drug Review, NPC President and Chief Executive Officer Dan Leonard considers the challenges in measuring and paying for value in health care, particularly when it comes to biopharmaceuticals.
Duke Margolis-NPC Postdoctoral Health Policy Fellow Taruja Karmarkar, PhD, sat down with us to discuss her upcoming research, bridging the gap between academia and health care stakeholders, tips for recent graduates, and more.
In this guest blog post, Dr. Eberechukwu Onukwugha of the University of Maryland School of Pharmacy's Department of Pharmaceutical Health Services Research explores the value of real-world data.
In a commentary published in STAT, National Pharmaceutical Council Executive Vice President and Chief Science Officer Robert Dubois, MD, PhD, outlines some creative thinking behind how we could innovate payment models to finance curative therapies for cancers and other rare diseases.